BD0635853
5,6-Diamino-1,3-dimethylpyrimidine-2,4(1H,3H)-dione , 98% , 5440-00-6
Synonym(s):
4,5-Diamino-1,3-dimethyl-2,6-dioxotetrahydropyrimidine;5,6-Diamino-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione;5,6-Diamino-1,3-dimethyluracil hydrate;NSC 15493
CAS NO.：5440-00-6
Empirical Formula: C6H10N4O2
Molecular Weight: 170.17
MDL number: MFCD00006551
EINECS: 226-621-9
| Pack Size | Price | Stock | Quantity |
| 250mg | RMB142.40 | In Stock |
|
| 1g | RMB352.80 | In Stock |
|
| 5g | RMB1235.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 210-214 °C (dec.)(lit.) |
| Boiling point: | 243.6±50.0℃ (760 Torr) |
| Density | 1.350±0.06 g/cm3 (20 ºC 760 Torr) |
| Flash point: | 101.1±30.1℃ |
| storage temp. | 2-30°C |
| solubility | DMSO, Methanol |
| form | Solid |
| pka | 4.42±0.70(Predicted) |
| color | Pale Brown |
| BRN | 157451 |
| EPA Substance Registry System | 2,4(1H,3H)-Pyrimidinedione, 5,6-diamino-1,3-dimethyl- (5440-00-6) |
Description and Uses
Reactant involved in the synthesis of biologically active molecules including:
- 1H-Imidazol-1-yl substituted 8-phenylxanthines for use as adenosine receptor ligands
- Pyrimidinyl purinediones via cyclocondensation
- Theophylline derivatives as adenosine receptor antagonists
- Pteridine analogs for use as monoamine oxidase B and nitric oxide synthase inhibitors
- Fused tricyclic xanthines
- Cadmium uraciliminoethylpyridine complexes for use as antiproliferatives against C6 glioma cells
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P305+P351+P338 |
| WGK Germany | 3 |
| F | 10-34 |
